Company Announcements

MGL Debt Instrument Program - Annual Update 2022

Source: RNS
RNS Number : 9406O
Macquarie Group Ltd
15 June 2022


Publication of Base Prospectus

The following base prospectus as part of an Offering Memorandum (the Base Prospectus) has been approved by the Financial Conduct Authority and is available for viewing:

Macquarie Group Limited 
Debt Instrument Programme dated 10 June 2022

To view the full document, please paste the following URL into the address bar of your browser.

A copy of the Base Prospectus has also been submitted to the National Storage Mechanism and will shortly be available for inspection at

For further information, please contact:


Macquarie Group Limited 

Mr. Angus Cameron
50 Martin Place

Sydney   NSW


Telephone : +61 2 8232 3333

Fax : +61 2 8232 4227

Email :


Please note that the information contained in the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed.  Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.